RecruitingNot ApplicableNCT06440915

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children


Sponsor

Shanghai Children's Medical Center

Enrollment

200 participants

Start Date

Jun 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn the plasma concentration of isavuconazole in pediatric patients. It will also learn about the relationship of isavuconazole plasma concentrations to efficacy and safety in pediatric patients. The main questions it aims to answer are: What is the plasma concentration after using isavuconazole in pediatric patients? What is the effective range of plasma concentration of isavuconazole in pediatric patients? What is the safe range of plasma concentration of isavuconazole in pediatric patients? Researchers will measure the plasma concentration of isavuconazole to see whether it is appropriate. Participants will: Take drug isavuconazole as prescribed by the doctor; 1mL of blood is drawn 30min before the next dose.


Eligibility

Max Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Isavuconazole and Theraputic drug monitoring for people with aspergillosis invasive and mucormycosis. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTheraputic drug monitoring

High Performance Liquid Chromatography (HPLC) is used to determine the plasma concentrations of isavuconazole

DRUGIsavuconazole

Isavuconazole


Locations(1)

Shanghai Children's Medical Center

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06440915


Related Trials